Gazi University Dspace
Not a member yet
26981 research outputs found
Sort by
Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity
Background Dual inhibitors of the 5-lipoxygenase-activating protein
(FLAP) and the microsomal prostaglandin E-2 synthase-1 (mPGES-1) may
exert better anti-inflammatory efficacy and lower risks of adverse
effects versus non-steroidal anti-inflammatory drugs. Despite these
advantages, many dual FLAP/mPGES-1 inhibitors are acidic lipophilic
molecules with low solubility and strong tendency for plasma protein
binding that limit their bioavailability and bioactivity. Here, we
present the encapsulation of the dual FLAP/mPGES-1 inhibitor BRP-187
into the biocompatible polymers acetalated dextran (Acdex) and
poly(lactic-co-glycolic acid) (PLGA) via nanoprecipitation. Results The
nanoparticles containing BRP-187 were prepared by the nanoprecipitation
method and analyzed by dynamic light scattering regarding their
hydrodynamic diameter, by scanning electron microscopy for morphology
properties, and by UV-VIS spectroscopy for determination of the
encapsulation efficiency of the drug. Moreover, we designed fluorescent
BRP-187 particles, which showed high cellular uptake by leukocytes, as
analyzed by flow cytometry. Finally, BRP-187 nanoparticles were tested
in human polymorphonuclear leukocytes and macrophages to determine drug
uptake, cytotoxicity, and efficiency to inhibit FLAP and mPGES-1.
Conclusion Our results demonstrate that encapsulation of BRP-187 into
Acdex and PLGA is feasible, and both PLGA- and Acdex-based particles
loaded with BRP-187 are more efficient in suppressing 5-lipoxygenase
product formation and prostaglandin E-2 biosynthesis in intact cells as
compared to the free compound, particularly after prolonged
preincubation periods